Mantle cell lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of B-cells in the mantle zone of lymphoid follicles. When it involves intrathoracic lymph nodes, it can lead to significant clinical manifestations, including respiratory symptoms and systemic effects. The ICD-10 Code C83.12 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively communicate the presence of this malignancy.
What is ICD-10 Code C83.12 for Mantle cell lymphoma, intrathoracic lymph nodes?
ICD-10 Code C83.12 specifically denotes mantle cell lymphoma affecting the intrathoracic lymph nodes. This condition arises from the malignant transformation of B-cells and is associated with various clinical symptoms, including lymphadenopathy and respiratory distress. This code should be utilized in clinical documentation and billing when a patient is diagnosed with this specific type of lymphoma, ensuring accurate representation of the patient's condition.
ICD-10 Code C83.12 – Clinical Definition and Explanation of Mantle cell lymphoma, intrathoracic lymph nodes
Mantle cell lymphoma, particularly when it involves intrathoracic lymph nodes, is a serious hematological malignancy that requires prompt medical attention. It is characterized by the uncontrolled growth of B-cells, leading to lymphadenopathy and potential respiratory complications. Early diagnosis and treatment are crucial for improving patient outcomes.
Key Clinical Features:
- Presence of enlarged lymph nodes in the thoracic cavity.
- Symptoms may include cough, chest pain, and dyspnea.
- Commonly affects middle-aged adults, with a higher prevalence in males.
- Associated with advanced disease stages and poorer prognosis.
ICD-10 Code C83.12 for Mantle cell lymphoma, intrathoracic lymph nodes – SOAP Notes & Clinical Use
In clinical workflows, ICD-10 Code C83.12 is essential for documenting the diagnosis of mantle cell lymphoma affecting intrathoracic lymph nodes. It aids in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
What Does ICD-10 Code C83.12 for Mantle cell lymphoma, intrathoracic lymph nodes Mean in SOAP Notes?
ICD-10 Code C83.12 connects subjective patient reports and objective clinical findings to a formal diagnosis of mantle cell lymphoma involving intrathoracic lymph nodes. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Treatment Options for ICD-10 Code C83.12 – Mantle cell lymphoma, intrathoracic lymph nodes
The management of mantle cell lymphoma involving intrathoracic lymph nodes often necessitates hospitalization due to the potential for severe complications. Treatment typically includes chemotherapy and may involve targeted therapies.
Antibiotic Therapy:
- Not applicable as mantle cell lymphoma is not an infectious condition.
Supportive Care:
- Symptom management including pain control and respiratory support.
- Nutritional support to maintain strength during treatment.
- Psychosocial support for emotional well-being.
Infection Control:
- Standard precautions to prevent infections in immunocompromised patients.
- Monitoring for signs of infection during treatment.
How to Document Symptoms of Mantle cell lymphoma, intrathoracic lymph nodes (ICD-10 C83.12) in SOAP Notes
Subjective:
- Patient reports persistent cough and chest discomfort.
- History of unexplained weight loss over the past few months.
- Complaints of night sweats and fatigue.
- Family history of lymphoma.
Objective:
- Physical examination reveals enlarged supraclavicular and mediastinal lymph nodes.
- Chest X-ray shows mediastinal widening.
- Vital signs: BP 120/80, HR 88, RR 20, SpO2 95% on room air.
- Laboratory results indicate elevated LDH levels.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Mantle cell lymphoma, intrathoracic lymph nodes (ICD-10 Code C83.12)
Assessment:
- Diagnosis: Mantle cell lymphoma, intrathoracic lymph nodes, stage II.
- ICD-10 Code: C83.12.
- Contributing factors include age and gender predisposition.
- Symptoms consistent with advanced lymphoma.
Plan:
- Initiate chemotherapy regimen including cyclophosphamide, doxorubicin, vincristine, and prednisone.
- Provide education on potential side effects and symptom management.
- Schedule follow-up appointments for monitoring treatment response.
- Consider referral to oncology for specialized care.
Treatment & Plan Section for ICD-10 Code C83.12 – Mantle cell lymphoma, intrathoracic lymph nodes
- First-line pharmacologic treatment includes R-CHOP chemotherapy regimen.
- Non-pharmacologic strategies include nutritional counseling and psychosocial support.
- Monitoring through regular imaging and laboratory tests to assess treatment efficacy.
- Follow-up visits to adjust treatment plans based on patient response.
Using ICD-10 Code C83.12 for Mantle cell lymphoma, intrathoracic lymph nodes in Billing & SOAP Note Compliance
- Select appropriate ICD-10 code based on clinical documentation of the diagnosis.
- Ensure Subjective (S) and Objective (O) sections reflect the patient's symptoms and clinical findings.
- Align treatment plans with established clinical guidelines to support justified billing.
- Document all relevant CPT codes that correspond with the services provided.
Related ICD-10 Codes Often Used with Mantle cell lymphoma, intrathoracic lymph nodes
- C83.11 – Mantle cell lymphoma, lymph nodes of head, face, and neck
- C83.19 – Mantle cell lymphoma, other sites
ICD-10 Code C83.12 in Medical Billing and Insurance for Mantle cell lymphoma, intrathoracic lymph nodes
ICD-10 Code C83.12 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring proper reimbursement for services rendered.
Billing Notes:
- Document all relevant patient history and clinical findings to support the use of this code.
- Use this code in conjunction with specific CPT codes for chemotherapy and supportive care.
- Ensure that the diagnosis is clearly linked to the treatment provided in the medical record.
- Review payer guidelines for any specific documentation requirements related to this diagnosis.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.12 for Mantle cell lymphoma, intrathoracic lymph nodes
What are the common symptoms of mantle cell lymphoma?
Common symptoms include swollen lymph nodes, unexplained weight loss, fever, night sweats, and fatigue. Patients may also experience respiratory symptoms if intrathoracic lymph nodes are involved.
How is mantle cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of malignant B-cells.
What treatment options are available for mantle cell lymphoma?
Treatment often includes chemotherapy, targeted therapy, and sometimes stem cell transplantation. Supportive care is also crucial for managing symptoms and side effects.
Is mantle cell lymphoma curable?
While mantle cell lymphoma is considered challenging to treat, advancements in therapy have improved outcomes. Some patients may achieve remission, but ongoing management is often necessary.
